PT-141 vs Melanotan II: How These Two Melanocortin Peptides Compare

PT-141 (bremelanotide) is an FDA-approved prescription drug for low sexual desire in premenopausal women, while Melanotan II is an unapproved tanning peptide sold online as a research chemical. Both act on melanocortin receptors and both can affect libido or trigger erections, but they differ sharply in legal status, dosing, and how much safety data exists. Understanding where these two peptides overlap — and where they don't — matters before considering either one.

What Is PT-141 (Bremelanotide)?

PT-141 is a synthetic peptide that activates melanocortin receptors, particularly MC4R in the brain, which plays a role in sexual desire. The FDA approved it in 2019 under the brand name Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women.

It is delivered as a 1.75 mg subcutaneous injection into the thigh or abdomen, typically about 45 minutes before anticipated sexual activity. The label limits use to one dose in 24 hours and no more than eight doses per month.

• Generic name: bremelanotide
• Brand name: Vyleesi
• Route: subcutaneous autoinjector
• Approved use: HSDD in premenopausal women
• Off-label use: erectile dysfunction and low libido in men

What Is Melanotan II?

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone. Researchers developed it in the 1980s as a tanning agent, then noticed that study participants were developing spontaneous erections.

No regulatory agency has approved Melanotan II for any human use. It is typically sold as a lyophilized powder labeled "for research use only," which is a legal workaround rather than a medical endorsement.

Because the supply is unregulated, products sold as Melanotan II vary widely in purity, actual peptide content, and sterility. Independent testing has repeatedly found that some vials contain little or none of the labeled peptide.

PT-141 vs Melanotan II: Side-by-Side Comparison

Factor	PT-141 (Bremelanotide)	Melanotan II
FDA status	Approved (Vyleesi, 2019)	Not approved for any use
Primary marketed purpose	Low sexual desire in premenopausal women	Tanning and skin darkening
Receptors targeted	MC4R, with activity at MC1R and MC3R	MC1R, MC4R, MC3R, MC5R
Typical dose	1.75 mg subcutaneous	0.5 mg to 1 mg subcutaneous (user-reported)
Duration of effect	Roughly 2 to 6 hours	Several hours for libido; days for pigmentation
Common side effects	Nausea, flushing, headache, injection site reactions	Nausea, flushing, yawning, darkening of moles
Legal status	Prescription only	Unapproved; illegal to sell as a drug

People searching pt 141 vs melanotan often want a simple answer about which one is stronger. The more useful answer is that only one of the two has a standardized dose and a reviewed safety profile.

Dosing and How Each Peptide Is Used

PT-141 dosing is fixed because the drug went through clinical trials and FDA review. Patients use one 1.75 mg autoinjector, and the prescribing information discourages exceeding one dose per day or eight doses per month.

Melanotan II has no established human dose. Online forums circulate numbers like 0.5 mg to 1 mg per injection, but those figures come from anecdotal reports rather than controlled trials. Without a standard, consistent dosing is nearly impossible.

Delivery route is another dividing line. Anyone weighing pt-141 nasal spray vs injection is usually looking at compounded or grey-market products, since the FDA-approved version is injection-only and no nasal formulation has been cleared for sale in the United States.

How these compare with other options

Some people investigate entirely different pathways. Kisspeptin works upstream on the reproductive hormone cascade rather than on melanocortin receptors, so a comparison of kisspeptin vs pt-141 is really a comparison of two distinct mechanisms rather than two versions of the same drug.

Prescription erectile dysfunction injections such as trimix work through local vasodilation instead of the central nervous system. That difference in mechanism is why pt-141 vs trimix discussions usually focus on onset time and how the drug reaches its target.

Brand and generic versions of bremelanotide are the same molecule at the same dose. A vyleesi vs pt-141 comparison is therefore a brand-versus-generic question, not a comparison of two different peptides.

Side Effects and Safety Differences

PT-141 side effects are documented in clinical trials. Nausea is the most frequently reported reaction, followed by flushing, headache, and injection site reactions. The label also notes a temporary rise in blood pressure, so the drug is not recommended for people with uncontrolled hypertension or known cardiovascular disease.

Melanotan II shares the nausea and flushing because it stimulates overlapping receptors, but it adds risks that come with unregulated peptides. User reports describe darkening of existing moles, new moles, and facial freckling.

Because MC1R stimulation drives pigment production, researchers have raised concerns about long-term melanoma risk with repeated Melanotan II use. That risk has not been ruled out by controlled safety studies, largely because none exist.

Neither peptide replaces a medical evaluation for low libido or erectile dysfunction, which can have cardiovascular, hormonal, medication-related, or psychological causes.

Talk with a healthcare professional before using any peptide for sexual or cosmetic purposes, especially if you take blood pressure medication or antidepressants, or if you have a personal or family history of skin cancer.

Legal Status and Availability

PT-141 requires a prescription in the United States and is dispensed through specialty pharmacies. Compounded bremelanotide exists but is not FDA-approved, and its quality can vary between sources.

Melanotan II has no legal pathway for human use in the US. The FDA has issued warning letters about Melanotan II products, and selling the peptide as a tanning drug is illegal. State possession rules differ, but ordering it online still means buying an unapproved, unverified substance.

Which One Fits a Given Situation?

• Low sexual desire in premenopausal women: PT-141 is the only one of the two with an FDA-approved indication and a defined dose.
• Tanning: Neither peptide is a safe shortcut. Melanotan II is unapproved and carries pigment-cell concerns, and PT-141 does not reliably darken skin at approved doses.
• Erection support in men: PT-141 has been studied for this off-label use, but it is not approved for it. Melanotan II has only anecdotal reports.

The bottom line is that PT-141 and Melanotan II are chemical cousins, not interchangeable products. One has a regulated dose, a reviewed label, and prescription oversight; the other has neither.

COMMON QUESTIONS

Frequently Asked Questions

Is PT-141 safer than Melanotan II?

PT-141 has a documented safety profile from FDA-reviewed clinical trials, with nausea, flushing, and headache as the most common side effects. Melanotan II has never been through that process, so its risks are estimated from user reports and animal data. That gap in evidence is the biggest safety difference between the two.

Is PT-141 FDA-approved for men?

No. Vyleesi (bremelanotide) is approved only for hypoactive sexual desire disorder in premenopausal women. Men sometimes use PT-141 off-label for erectile dysfunction, and it has been studied in trials for that purpose, but the FDA has not cleared it for male use.

Can you legally buy Melanotan II in the United States?

Melanotan II is not approved for human use, so it cannot be legally sold as a drug or dietary supplement. Products labeled "for research use only" are a common workaround, but they are unregulated in purity and potency. Importing or selling it for human consumption can carry legal risk.